False elevations in prostate-specific antigen levels affecting patient management.
Kummar
Shivaani
S
VA Connecticut Cancer Center, Yale Cancer Center, West Haven, CT 06516, USA. sk157a@nih.gov <sk157a@nih.gov>
Shafi
Nelofar Q
NQ
D000230:Adenocarcinoma / Q000097:blood* / Q000188:drug therapy / Q000276:immunology / Q000532:radiotherapy / Q000601:surgery; D000726:Androgen Antagonists / Q000627:therapeutic use; D000910:Antibodies, Heterophile / Q000276:immunology*; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm / Q000276:immunology; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood* / Q000276:immunology; D019090:Case Management; D003429:Cross Reactions; D005189:False Positive Reactions; D005500:Follow-Up Studies; D006801:Humans; D007124:Immunoenzyme Techniques; D015592:Immunoradiometric Assay; D008163:Luminescent Measurements; D008297:Male; D008863:Microspheres; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000097:blood* / Q000276:immunology; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D017430:Prostate-Specific Antigen / Q000097:blood* / Q000276:immunology; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000276:immunology / Q000532:radiotherapy / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D019564:Unnecessary Procedures
D000726:Androgen Antagonists; D000910:Antibodies, Heterophile; D000951:Antigens, Neoplasm; D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D017430:Prostate-Specific Antigen